Related by context. Frequent words. (Click for all words.) 79 Chronic Hepatitis C 77 Chronic Hepatitis B 74 Advanced Prostate Cancer 74 Well Tolerated 74 Monotherapy 74 Clinical Trial Results 74 Renal Cell Carcinoma 73 Elderly Patients 73 Drug Candidate 73 Completes Enrollment 73 Drug Resistant 73 Phase III Clinical Trial 73 Single Dose 73 Metastatic Colorectal Cancer 72 Preclinical Data 71 Patients Treated 71 Smallpox Vaccine 71 Patient Enrollment 71 Patients Undergoing 71 Prostate Cancer Patients 71 Phase III Trial 70 Presents Positive 70 Combination Therapy 70 II Clinical Trial 70 Pivotal Study 70 Lung Cancer Patients 70 Pulmonary Arterial Hypertension 70 Pediatric Patients 70 Blood Thinner 69 Postmenopausal Women 69 FDA Accepts 69 Diabetic Patients 69 FDA Clears 69 Metastatic Melanoma 69 Recombinant Human 69 Newly Diagnosed 69 Initiates Phase II 69 Pivotal Phase 69 Significantly Reduces 69 Cervical Cancer Vaccine 69 Cholesterol Drug 68 Initiate Phase 68 Gastric Cancer 68 Relapsed 68 Cardiovascular Events 68 Study Demonstrates 68 Gene Mutation 68 Breast Cancer Treatment 68 Regimens 68 Tumor Growth 68 Pivotal Phase III 68 Hepatitis C Virus 68 Monoclonal Antibody 68 Reduces Risk 68 FDA Approves 68 Initiates Phase 68 Generic Version 67 Develop Novel 67 Increased Risk 67 Positive Opinion 67 Breast Cancer Patients 67 RNAi Therapeutics 67 Pivotal Trial 67 Heart Failure Patients 67 Shows Promise 67 Malaria Vaccine 67 Meta Analysis 67 Epratuzumab 67 Solid Tumors 67 Chronic Lymphocytic Leukemia 67 Racivir 67 Golimumab 67 Boceprevir 67 refractory chronic lymphocytic 66 Low Dose 66 Announces Initiation 66 Commences Phase 66 Chronic Heart Failure 66 Prostate Cancer Treatment 66 Overactive Bladder 66 Insulin Resistance 66 Randomized Controlled Trial 66 Bird Flu Vaccine 66 Receives FDA Clearance 66 D' SOUZA KARKALA CHAD 66 Flu Vaccines 66 Venous Thromboembolism 66 Diabetic Macular Edema 66 Kidney Failure 66 Urinary Incontinence 66 Significantly Improves 65 Belimumab 65 Benign Prostatic Hyperplasia 65 Anthrax Vaccine 65 Induces 65 Community Acquired Pneumonia 65 Adalimumab 65 Clinical Trials Update 65 Inhibits 65 Achieves Milestone 65 Anti TNF